Abstract
Reports indicate that the prevalence of gastrointestinal involvement of Behçet’s disease (BD) shows geographic variation. Since no true population surveys are available, at least some of this variation could be due to selection bias. The usually reported prevalence is less than 1% among patients from the Western countries and the Middle East while this frequency becomes 10% or higher in the Far East with reports of around 25% from Japan. As in Crohn’s disease (CD), gastrointestinal Behçet’s disease (GIBD) is seen most commonly in the ileocecal area. Lesions in the esophagus and stomach are distinctly rare. It is quite difficult to differentiate GIBD from CD disease unless other stigmata of either condition are present. The rarity of rectal involvement and the absence of granulomas in GIBD can on occasion be helpful. On the other hand, the presence of these two features in CD (∼10% for rectal disease and 10–15% for granuloma formation) is not frequent either, reducing their usefulness in differential diagnosis. Thus far, outcome perforation is more common in GIBD (25–50%) than in Crohn’s (∼2%). Management of GIBD is very similar to what we do in CD. Surgical treatment is reserved for complications like perforation, bleeding, obstruction, and stubborn fistula formation. Since relapses are frequent even under medical treatment, surgical resection should be conservative.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bechgaard P (1940) Et tilfaelds af recidiverende aphtos stomatitis ledsaget af conjunctivitis og ulcerationer paa genitalia og hud. Ugeskr Laeger 102:1019–1023
Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet’s disease (Behçet syndrome). Semin Arthritis Rheum 8(4):223–260
Lee SK, Kim WH (2006) Diagnostic challenges in Asia: intestinal Behçet’s disease. Falk Symp 151:1–13
Yang SK (2005) Intestinal Behçet’s disease. Intest Res 3(1):1–10
Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Behçet’s disease. Semin Arthritis Rheum 27(4):197–217
O’Duffy JD, Carney A, Deodhar S (1971) Behçet’s disease: report of 10 cases, 3 with new manifestation. Ann Intern Med 75:561–570
Eun HC, Chung H, Choi SJ (1984) Clinical analysis of 114 patients with Behçet’s disease. J Korean Med Assoc 27:933–939
Chamberlain MA (1977) Behçet’s syndrome in 32 patients in Yokshire. Ann Rheum Dis 36:491–499
Dilsen N, Konice M, Aral O et al (1993) Risk factors of vital organ involvement in Behçet’s disease. In: Weschler B, Godeau F (eds) Behçet’s disease, Proceedings of the Sixth International Conference on Behçet’s Disease. Excerpta Medica, Amsterdam, pp 165–169
Jankowski J, Crombi I, Jankowski R (1992) Behçet’s syndrome in Scotland. Post Med J 68:566–570
Bang D, Lee JH, Lee ES et al (2001) Epidemiologic and clinical survey of Behçet’s disease in Korea: the first multicenter study. J Korean Med Sci 16:615–618
Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis 55(3):208–210
Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behçets disease: an analysis of 2147 patients. Yonsei Med J 38(6):423–427
Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behçet’s disease in Korea. Yonsei Med J 38(6):428–436
Kural-Seyahi E, Ozdogan H, Yurdakul S, Ugurlu S, Ozyazgan Y, Mat C et al (2004) The outcome of the children with Behçet’s syndrome. Clin Exp Rheumatol 22(Suppl 34):116a
Chang HK, Kim JW (2002) The clinical features of Behçet’s disease in Yongdong district: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17:784–789
Ng FH, Cheung TC, Chow KC, Wong SY, Ng WF, Chan HC et al (2001) Repeated intestinal perforation caused by an incomplete form of Behçet’s syndrome. J Gastroenterol Hepatol 16(8):935–939
Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol 42(5):346–351
Yi SW, Cheon JH, Kim JH, Lee SK, Kim TI, Lee YC et al (2009) The prevalence and clinical characteristics of esophageal involvement in patients with Behçet’s disease: a single center experience in Korea. J Korean Med Sci 24(1):52–56
Mizushima Y, Inaba G, Mimura Y, Ono S (1988) Diagnostic criteria for Behçet’s disease in 1987, and guidelines for treating Behçet’s disease. Saishin Igaku 43:382–391
Bayraktar Y, Ozaslan E, Van Thiel DH (2000) Gastrointestinal manifestations of Behçet’s disease. J Clin Gastroenterol 30(2):144–154
Sfikakis PP (2002) Behçet’s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):ii51–ii53
Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Yalcin B, Muftuoglu A (1980) Behçet’s disease as seen in Turkey. Haematologica 65(3):381–383
Bottomley WW, Dakkak M, Walton S, Bennett JR (1992) Esophageal involvement in Behçet’s disease. Is endoscopy necessary? Dig Dis Sci 37(4):594–597
Houman MH, Ben Ghorbel I, Lamloum M, Khanfir M, Braham A, Haouet S et al (2002) Esophageal involvement in Behçet’s disease. Yonsei Med J 43(4):457–460
Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T (1981) Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 24(2):103–106
Ning-Sheng L, Ruay-Sheng L, Kuo-Chih T (2005) High frequency of unusual gastric/duodenal ulcers in patients with Behçet’s disease in Taiwan: a possible correlation of MHC molecules with the development of gastric/duodenal ulcers. Clin Rheumatol 24(5):516–520
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341(17):1284–1291
Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H et al (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 43(6):783–789
Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS et al (2000) Long-term clinical course and prognostic factors in intestinal Behçet’s disease. Dis Colon Rectum 43(5):692–700
Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS et al (2001) Colonoscopic findings in intestinal Behçet’s disease. Inflamm Bowel Dis 7(3):243–249
Kim DK, Yang SK, Byeon JS, Myung SJ, Jo JY, Choi KD et al (2005) Clinical manifestations and course of intestinal Behçet’s disease: an analysis in relation to disease subtypes. Intest Res 3(1):48–54
Lang BA, Laxer RM, Thorner P, Greenberg M, Silverman ED (1990) Pediatric onset of Behçet’s syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum 33(3):418–425
Wu PS, Chen HL, Yang YH, Jeng YM, Lee PI, Chang MH (2005) Intestinal Behçet’s disease presenting as neonatal onset chronic diarrhea in an 11-month-old male baby. Eur J Pediatr 164(8):523–525
Fujikawa S, Suemitsu T (1997) Behçet’s disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn 39(2):285–289
Tabata M, Tomomasa T, Kaneko H, Morikawa A (1999) Intestinal Behçet’s disease: a case report and review of Japanese reports in children. J Pediatr Gastroenterol Nutr 29(4):477–481
Bang DS, Oh SH, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci 18(2):231–235
Isik B, Ara C, Kirimlioglu H, Sogutlu G, Yilmaz M, Yilmaz S et al (2005) Single or multiple perforations with varying locations as a complication of intestinal Behçet’s disease: report of three cases. Scand J Gastroenterol 40(5):599–603
Pirildar T, Keser G, Tunc E, Alkanat M, Tuncyurek M, Doganavsargil E (2001) An unusual presentation of Behçet’s disease: intestinal perforation. Clin Rheumatol 20(1):61–62
Lee RG (1986) The colitis of Behçet’s syndrome. Am J Surg Pathol 10(12):888–893
Iwama T, Utzunomiya J (1977) Anal complication in Behçet’s syndrome. Jpn J Surg 7(3):114–117
Kim SU, Cheon JH, Lim JS, Paik SH, Kim SK, Lee SK et al (2007) Massive gastrointestinal bleeding due to aneurysmal rupture of ileo-colic artery in a patient with Behçet’s disease. Korean J Gastroenterol 49(6):400–404
Smith JA, Siddiqui D (2002) Intestinal Behçet’s disease presenting as a massive acute lower gastrointestinal bleed. Dig Dis Sci 47(3):517–521
Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG (1999) Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn’s disease and intestinal Behçet’s disease. Int J Colorectal Dis 14(1):52–57
Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 70(3):439–444
Cheon JH, Han DS, Park JY, Ye BD, Jung SA, Young Sook Park, You Sun Kim, Joo Sung Kim, Chung Mo Nam, Youn Nam Kim, Suk-Kyun Yang, Won Ho Kim (2010). Development, Validation, and Responsiveness of a Novel Disease Activity Index for Intestinal Behçet’s Disease. Inflamm Bowel Dis (in press)
Mori S, Yoshihira A, Kawamura H, Takeuchi A, Hashimoto T, Inaba G (1983) Esophageal involvement in Behçet’s disease. Am J Gastroenterol 78(9):548–553
Yashiro K, Nagasako K, Hasegawa K, Maruyama M, Suzuki S, Obata H (1986) Esophageal lesions in intestinal Behçet’s disease. Endoscopy 18(2):57–60
Anti M, Marra G, Rapaccini GL, Barone C, Manna R, Bochicchio GB et al (1986) Esophageal involvement in Behçet’s syndrome. J Clin Gastroenterol 8(5):514–519
Brodie TE, Ochsner JL (1973) Behçet’s syndrome with ulcerative oesophagitis: report of the first case. Thorax 28(5):637–640
Morimoto Y, Tanaka Y, Itoh T, Yamamoto S, Kurihara Y, Nishikawa K (2005) Esophagobronchial fistula in a patient with Behçet’s disease: report of a case. Surg Today 35(8):671–676
Celik AF, Hatemi I (2005) Gastrointestinal involvement of Behçet’s syndrome. Turkiye Klinikleri J Int Med Sci 1:48–54
Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C et al (2008) Frequency of pathergy phenomenon and other features of Behçet’s syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol 26(Suppl 50):S91–95
Iscimen A, Imren S, Serdaroglu S, Kutlar M et al (1987) The significance of genital scars in the diagnosis of Behçet’s syndrome. In: 11th European congress of rheumatology, Athens, Greece, June 28 to July 4, p F327
Mat CM, Goksungur N, Engin B, Yurdakul S, Yazici H (2006) The frequency of scarring after ulcers in Behçet’s syndrome: a prospective study. Int J Dermatol 45:554–556
Lee SK, Kim BK, Kim TI, Kim WH (2009) Differential diagnosis of intestinal Behçet’s Disease and Crohn’s disease by colonoscopic findings. Endoscopy 41(1):9–16
Fresko I, Ugurlu S, Ozbakır F, Celik A, Yurdakul S, Hamuryudan V et al (2005) Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet’s syndrome. Clin Exp Rheumatol 23(Suppl 38):S67–S70
Byeong GK, You SK, Joo SK, Hyun CJ, In SS (2002) Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel diseases. Dis Colon Rectum 45:1062–1069
Kim JS, Lim SH, Choi IJ, Moon H, Jung HC, Song IS et al (2000) Prediction of the clinical course of Behçet’s colitis according to macroscopic classification by colonoscopy. Endoscopy 32(8):635–640
Pulimood AB, Ramakrishna BS, Kurian G, Peter S, Mathan MM (1999) Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis. Gut 45:537–541
Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH (2008) Budd–Chiari syndrome associated with Behçet’s disease. Gastroenterol Clin Biol 32(3):316–320
Park JJ, Cheon JH, Kim TI, Kim WH (2009) Correlation of erythrocyte sedimentation rate and C-reactive protein with clinical disease activity in intestinal Behçet’s disease. Gut58(suppl 2):A461
Muftuoglu AU, Yazici H, Yurdakul S, Tuzun Y, Pazarli H, Gungen G et al (1986) Behçet’s disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 25(4):235–239
Quinton J-F, Sendid B, Reumaux D, Cortot A, Grandbastien B, Charrier G et al (1988) Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic auto-antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788–791
Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH et al (2006) Anti-Saccharomyces cerevisiae antibody in intestinal Behçet’s disease patients: relation to clinical course. Dis Colon Rectum 49(12):1849–1859
Krause I, Monselise Y, Milo G, Weinberger A (2002) Anti-Saccharomyces cerevisiae antibodies – a novel serologic marker for Behçet’s disease. Clin Exp Rheumatol 20(Suppl 26):S21–S24
Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM (2007) Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn’s disease and intestinal tuberculosis. Dig Dis Sci 52(1):33–39, Epub 2006 Dec 8
Chang DK, Kim JJ, Choi H, Eun CS, Han DS, Byeon JS et al (2007) Double balloon endoscopy in small intestinal Crohn’s disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc 66(Suppl 3):S96–S98
Hamdulay SS, Cheent K, Ghosh C, Stocks J, Ghosh S, Haskard DO (2008) Wireless capsule endoscopy in the investigation of intestinal Behçet’s syndrome. Rheumatology (Oxford) 47(8):1231–1234
Gubler C, Bauerfeind P (2005) Intestinal Behçet’s disease diagnosed by capsule endoscopy. Endoscopy 37(7):689
Thach BT, Cummings NA (1976) Behçet’s syndrome with “aphthous colitis”. Arch Intern Med 136(6):705–709
Lee KS, Kim SJ, Lee BC, Yoon DS, Lee WJ, Chi HS (1997) Surgical treatment of intestinal Behçet’s disease. Yonsei Med J 38(6):455–460
Lebwohl O, Forde KA, Berdon WE, Morrison S, Challop R (1977) Ulcerative esophagitis and colitis in a pediatric patient with Behçet’s syndrome. Response to steroid therapy. Am J Gastroenterol 68(6):550–555
Korman U, Cantasdemir M, Kurugoglu S, Mihmanli I, Soylu N, Hamuryudan V et al (2003) Enteroclysis findings of intestinal Behçet’s disease: a comparative study with Crohn disease. Abdom Imaging 28(3):308–312
Kim JH, Choi BI, Han JK, Choo SW, Han MC (1994) Colitis in Behçet’s disease: characteristics on double-contrast barium enema examination in 20 patients. Abdom Imaging 19(2):132–136
Chung SY, Ha HK, Kim JH, Kim KW, Cho N, Cho KS et al (2001) Radiologic findings of Behçet’s syndrome involving the gastrointestinal tract. Radiographics 21(4):911–924, discussion 24–26
Ha HK, Lee HJ, Yang SK, Ki WW, Yoon KH, Shin YM et al (1998) Intestinal Behçet’s syndrome: CT features of patients with and patients without complications. Radiology 209(2):449–454
Gullberg E, Soderholm JD (2006) Peyer’s patches and M cells as potential sites of the inflammatory onset in Crohn’s disease. Ann N Y Acad Sci 1072:218–232
Isomoto H, Shikuwa S, Suematsu T, Migita K, Ito M, Kohno S (2008) Ileal lesions in Behçet’s disease originate in Peyer’s patches: findings on magnifying endoscopy. Scand J Gastroenterol 43(2):249–250
Takada Y, Fujita Y, Igarashi M, Katsumata T, Okabe H, Saigenji K et al (1997) Intestinal Behçet’s disease pathognomonic changes in intramucosal lymphoid tissues and effect of a “rest cure” on intestinal lesions. J Gastroenterol 32(5):598–604
Nara K, Kurokawa MS, Chiba S, Yoshikawa H, Tsukikawa S, Matsuda T et al (2008) Involvement of innate immunity in the pathogenesis of intestinal Behçet’s disease. Clin Exp Immunol 152(2):245–251
Hayasaki N, Ito M, Suzuki T, Ina K, Ando T, Kusugami K et al (2004) Neutrophilic phlebitis is characteristic of intestinal Behçet’s disease and simple ulcer syndrome. Histopathology 45(4):377–383
Kobayashi M, Ito M, Nakagawa A, Matsushita M, Nishikimi N, Sakurai T et al (2000) Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology 36(4):362–371
Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13(3):93–100
Senturk T, Aydintug O, Kuzu I, Duzgun N, Tokgoz G, Gurler A et al (1998) Adhesion molecule expression in erythema nodosum-like lesions in Behçet’s disease. A histopathological and immunohistochemical study. Rheumatol Int 18(2):51–57
Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T (1985) Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16(8):790–795
Direskeneli H (2001) Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60(11):996–1002
Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H et al (2000) Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet’s disease. Am J Gastroenterol 95(10):2848–2851
Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C et al (2005) Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet’s disease. Clin Exp Immunol 139(2):371–378
Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W et al (2005) CARD15 polymorphisms in Behçet’s disease. Scand J Rheumatol 34:233–237
Ozen SC, Dagli U, Kilic MY, Toruner M, Celik Y, Ozkan M et al (2006) NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphism in Turkish patients with inflammatory bowel disease. J Gastroenterol 41:304–310
Uyar FA, Over-Hamzaoglu H, Ture F, Gul A, Tozun N, Saruhan-Direskeneli G (2006) Distribution of common CARD15 variants in patients sporadic Crohn’s disease cases from Turkey. Dig Dis Sci 51(4):706–710
Kobayashi T, Sudo Y, Okamura S, Ohashi S, Urano F, Hosoi T et al (2005) Monozygotic twins concordant for intestinal Behçet’s disease. J Gastroenterol 40(4):421–425
Hamuryudan V, Yurdakul S, Ozbakir F, Yazici H, Hekim H (1991) Monozygotic twins concordant for Behçet’s syndrome. Arthritis Rheum 34(8):1071–1072
Soy M, Erken E, Konca K, Ozbek S (2000) Smoking and Behçet’s disease. Clin Rheumatol 19:508–509
Kaklamani VG, Markkomichelakis N, Kaklamanis PG (2002) Could nicotine be beneficial for Behçet’s disease. Clin Rheumatol 21:341–342
Edward JB, Koepsell TD, Prera DR, Inuni TS (1987) Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 316:707–710
Somerville KW, Logan RFA, Edmond M, Langman MJS (1984) Smoking and Crohn’s disease. Br Med J 289:954–956
Fresko I, Hamuryudan V, Demir M, Hizli N, Sayman H, Melikoglu M et al (2001) Intestinal permeability in Behçet’s syndrome. Ann Rheum Dis 60(1):65–66
Koc B, Aymelek S, Sonmez A, Yilmaz MI, Kocar H (2004) Increased sucrose permeability in Behçet’s disease. Rheumatol Int 24(6):347–350
Kobayashi K, Ueno F, Bito S, Iwao Y, Fukushima T, Hiwatashi N et al (2007) Development of consensus statements for the diagnosis and management of intestinal Behçet’s disease using a modified Delphi approach. J Gastroenterol 42(9):737–745
Shin SJ, Kim BC, Park SY, Kim TI, Kim WH (2005) Systemic manifestations of Behçet’s disease in diagnosis of intestinal Behçet’s disease. Gut 55:A120
Jung HC, Rhee PL, Song IS, Choi KW, Kim CY (1991) Temporal changes in the clinical type or diagnosis of Behçet’s colitis in patients with aphthoid or punched-out colonic ulcerations. J Korean Med Sci 6(4):313–318
Cheon JH, Kim ES, Shin SJ et al (2009) Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet’s Disease in Korean Patients with Ileo-colonic Ulcers. Am J Gastroenterol 104(10):2492–2499
Yim CW, White RH (1985) Behçet’s syndrome in a family with inflammatory bowel disease. Arch Intern Med 145(6):1047–1050
Kim ES, Chung WC, Lee KM, Lee BI, Choi H, Han SW et al (2007) A case of intestinal Behçet’s disease similar to Crohn’s colitis. J Korean Med Sci 22(5):918–922
Naganuma M, Iwao Y, Kashiwagi K, Funakoshi S, Ishii H, Hibi T (2002) A case of Behçet’s disease accompanied by colitis with longitudinal ulcers and granuloma. J Gastroenterol Hepatol 17(1):105–108
Tolia V, Abdullah A, Thirumoorthi MC, Chang CH (1989) A case of Behçet’s disease with intestinal involvement due to Crohn’s disease. Am J Gastroenterol 84(3):322–325
Smith GE, Kime LR, Pitcher JL (1973) The colitis of Behçet’s disease: a separate entity? Colonoscopic findings and literature review. Am J Dig Dis 18(11):987–1000
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335(8697):1078–1080
Balthazar EJ, Gordon R, Hulnick D (1990) Ileocecal tuberculosis: CT and radiologic evaluation. AJR Am J Roentgenol 154(3):499–503
Puspok A, Keiner H, Oberhuber G (2000) Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 43:685–691
Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vagas R, Schnitzer TJ et al (2003) Serious lower gastrointestinal clinical events with nonselective NSAID or Coxib use. Gastroenterology 124:288–292
Celik AF, Pamuk ON, Melikoglu M, Yazici H (2008) How to diagnose Behçet’s and intestinal Behçet’s disease? In: Tozun N, Mantzaris, Daglı U, Schölmerich J (eds) IBD 2007-achievements in research and clinical practice. Springer, Dordrecht, pp 118–128
Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M (2001) Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol 96(2):473–480
Iida M (1992) Clinical course of intestinal lesions in patients with intestinal disease and simple ulcer. Stomach Intestine 27:287–302
Pallis AG, Mouzas IA, Vlachonikolis IG (2004) The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis 10(3):261–269
Park KD, Bang D, Lee ES, Lee SH, Lee S (1993) Clinical study on death in Behçet’s disease. J Korean Med Sci 8(4):241–245
Yoo HM, Han KH, Kim PS, Kim WH, Kang JK, Park IS et al (1997) Clinical features of intestinal Behçet’s disease and therapeutic effects of sulfasalazine. Korean J Gastroenterol 29:465–472
Houman MH, Hamzaoui K (2006) Promising new therapies for Behçet’s disease. Eur J Intern Med 17(3):163–169
Sonta T, Araki Y, Koubokawa M, Tamura Y, Ochiai T, Harada N et al (2000) The beneficial effect of mesalazine on esophageal ulcers in intestinal Behçet’s disease. J Clin Gastroenterol 30(2):195–199
Matsukawa M, Yamasaki T, Kouda T, Kurihara M (2001) Endoscopic therapy with absolute ethanol for postoperative recurrent ulcers in intestinal Behçet’s disease, and simple ulcers. J Gastroenterol 36(4):255–258
Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet’s syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128(6):443–450
Bariol C, Meagher AP, Vickers CR, Byrnes DJ, Edwards PD, Hing M et al (2002) Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease. J Gastroenterol Hepatol 17(2):135–139
Yasui K, Uchida N, Akazawa Y, Nakamura S, Minami I, Amano Y et al (2008) Thalidomide for treatment of intestinal involvement of juvenile-onset Behçet’s disease. Inflamm Bowel Dis 14(3):396–400
Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL (2001) Treatment of intestinal Behçet’s syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49(5):725–728
Kram MT, May LD, Goodman S, Molinas S (2003) Behçet’s ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum 46(1):118–121
Lee JH, Kim TN, Choi ST, Jang BI, Shin KC, Lee SB et al (2007) Remission of intestinal Behçet’s disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab). Korean J Intern Med 22(1):24–27
Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK et al (2007) Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet’s disease: report of a case. Dis Colon Rectum 50(5):672–676
Naganuma M, Sakuraba A, Hisamatsu T, Ochiai H, Hasegawa H, Ogata H et al (2008) Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet’s disease. Inflamm Bowel Dis 14(9):1259–1264
Hanauer SB (2003) Crohn’s disease: step up or top down therapy. Best Pract Res Clin Gastroenterol 17(1):131–137
Mussack T, Landauer N, Ladurner R, Schiemann U, Goetzberger M, Burchardi C et al (2003) Successful treatment of cervical esophageal perforation in Behçet’s disease with drainage operation and infliximab. Am J Gastroenterol 98(3):703–704
Ju JH, Kwok SK, Seo SH, Yoon CH, Kim HY, Park SH (2007) Successful treatment of life-threatening intestinal ulcer in Behçet’s disease with infliximab: rapid healing of Behçet’s ulcer with infliximab. Clin Rheumatol 26(8):1383–1385
Rossi G, Moretta A, Locatelli F (2004) Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behçet’s disease. Blood 103(2):748–750
Yamato K (2003) Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet’s disease. Int J Hematol 77(1):82–85
Sayek I, Aran O, Uzunalimoglu B, Hersek E (1991) Intestinal Behçet’s disease: surgical experience in seven cases. Hepatogastroenterology 38(1):81–83
Lida M, Kobayayashi H, Matsumoto T, Okada M, Fuchigami T, Yao T et al (1994) Postoperative recurrence in patients with intestinal Behçet’s disease. Dis Colon Rectum 37(1):16–21
Bozkurt M, Torin G, Aksakal B, Ataoglu O (1992) Behçet’s disease and surgical intervention. Int J Dermatol 31(8):571–573
Bradbury AW, Milne AA, Murie JA (1994) Surgical aspects of Behçet’s disease. Br J Surg 81(12):1712–1721
Chung MJ, Cheon JH, Kim SU, Park JJ, Kim TI, Kim NK (2010) Response rates to medical treatments and long-term clinical outcomes of non-surgical patients with intestinal Behçet’s disease. J Clin Gastroenterol Jan 5 [Epub ehead of print]
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V et al (2003) The long term mortality and morbidity of Behçet’s syndrome. A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
Uyar FA, Saruhan-Direskeneli G, Gül A (2004) Common Crohn’s disease predisposing variants of the CARD15/NOD2 genes are not associated with Behçet’s disease in Turkey. Clin Exp Rheumatol 22(Suppl 34):S50–S52
Hatemi I, Hatemi G, Senateş, Baysal B, Erzin Y, Celik AF (2008) Low dose thalidomide in immunosuppressive unresponsive IBD; effectiveness and side effects. Gastroenterology 132:4(Suppl 2):A665
Yamamoto T, Toyokkawa H, Matsubara JT et al (1974) A nation-wide survey of Behçet’s disease in Japan. I. Epidemiological survey. Jpn J Opthalmol 18:282–290
Cigerciogulları E, Goksel S, Dogusoy B, Erdamar S, Celik AF, Erzin Y et al (2005) An analysis of the reliability of detection and diagnostic value of various pathologic features in Crohn’s disease. Virchows Arch 447(2):P5O7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cheon, J.H., Çelik, A.F., Kim, W.H. (2010). Behçet’s Disease: Gastrointestinal Involvement. In: Yazıcı, Y., Yazıcı, H. (eds) Behçet’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5641-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5641-5_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5640-8
Online ISBN: 978-1-4419-5641-5
eBook Packages: MedicineMedicine (R0)